Hutch News Stories

Add 'crush' orange to your glassybaby collection to help obliterate cancer

Ten percent of sales of the new candleholders will support Obliteride—the bike ride to accelerate cancer research at Fred Hutchinson Cancer Research Center
Purchase glassybaby's "crush" through August and 10 percent of the proceeds will go to Obliteride to fund cancer research at Fred Hutch.

Another iconic Northwest company—glassybaby—is joining Obliteride and the Hutchinson Center to light Seattle orange in solidarity with the fight to extinguish cancer. The company has created a new "crush" votive candleholder for the fundraising bike ride Aug. 9-11. Purchase the vivid orange, handmade commemorative glassybaby through August and 10 percent of the proceeds will go to Obliteride to fund cancer research at Fred Hutch.
Seattle-based glassybaby has a personal connection to the cause. Founder Lee Rhodes is a three-time cancer survivor who made it the company's mission to help other cancer patients heal. From its beginning, glassybaby has donated money from sales to charities helping cancer patients, like the ones Rhodes met in chemo waiting rooms—patients who could not afford basic needs like bus fare and groceries.
"We admire Fred Hutch's mission to end cancer and save lives, and glassybaby joins them on this ride to help cancer patients and 'crush' cancer," Rhodes said.
Rhodes' glassybaby is a long-time friend of Fred Hutch. Since 2007 glassybaby has donated more than $100,000 to help cancer patients with day-to-day needs during treatment.
"We have a major crush on glassybaby, too," said Obliteride Executive Director Amy Lavin. "They are bringing warmth, healing and hope to cancer patients and our community. Thank you to glassybaby and everyone who is committed to obliterating cancer."
Join the community to 'crush' cancer

Purchase "crush" glassybaby votive now or at a glassybaby retail shop in Seattle or Bellevue.

The time is now to register for Obliteride. Ride, fundraise, volunteer or donate for the Aug. 9-11 event today at OBLITERIDE.ORG.


Help Us Eliminate Cancer

Every dollar counts. Please support lifesaving research today.

Last Modified, May 11, 2022